The study compared two laboratory methods for measuring the effectiveness of CFTR modulator drugs in nasal cell cultures from cystic fibrosis patients. The faster fluorescence-based assay produced results that correlated with the standard, slower electrophysiology method for cultures with the F508del mutation and showed potential for detecting responses in cultures with the W1282X mutation.